)
Visual22 Oct 2025
Epiroc's cash spent on M&A
Chosa Oncology (CHOSA) investor relations material
Chosa Oncology Q2 2025 earnings summary
Complete event summary combining all related documents: earnings call transcript, report, and slide presentation.Q2 2025 earnings summary28 Aug, 2025
Executive summary
Achieved key progress in clinical validation studies and expanded patient reach, with promising retrospective results in metastatic breast cancer using the DRP® platform for platinum-based therapies.
Initiated a retrospective validation study in lung cancer, leveraging data from the SPLENDOUR study, with results expected in Q3 2025.
Extended financial flexibility through a directed share issue and a rights issue, raising a total of 5 MSEK before costs.
Financial highlights
Other operating income for Q2 2025 was 677 TSEK, compared to 0 in Q2 2024.
Net result after financial items for Q2 2025 was 2,645 TSEK, up from -1,950 TSEK in Q2 2024.
Earnings per share for Q2 2025 were 0.037 SEK, compared to -0.32 SEK in Q2 2024.
Equity ratio as of June 30, 2025, was 88%, down from 91% a year earlier.
Cash and cash equivalents at June 30, 2025, were 1,876 TSEK, compared to 11,136 TSEK at June 30, 2024.
Outlook and guidance
Results from the SPLENDOUR lung cancer study are expected to be communicated in Q3 2025.
Poster presentation of carboplatin data accepted for ESMO Congress in October 2025.
Ongoing focus on licensing or partnering key assets, including LiPlaCis® and DRP® technologies.
SPLENDOUR lung cancer DRP validation status?
Post-Q2 cash position after capital raises?
Update on DRP/LiPlaCis partnering dialogues
Partial view of Summaries dataset, powered by Quartr API
Research faster. Power your platform.
Next Chosa Oncology earnings date
Q3 202513 Nov, 2025
Next Chosa Oncology earnings date
Q3 202513 Nov, 2025
The essential earnings season companion
The #1 app for live earnings calls, transcripts, analyst estimates, and more. All for free.
Live calls and transcripts
Listen to earnings calls, CMDs, investor conferences, and more – with a podcast-like experience.
Find what you need faster
Search for any keyword across all transcripts simultaneously.
Easily store key findings
Capturing important takeaways is as simple as it gets. Even during your lunch run or commute.
Your watchlist. Your dashboard.
Follow the companies that matter to you. Get a personalized feed with real-time updates.
Be the first to know
Set keyword alerts for any company, product, or competitor. Get notified the moment they're mentioned.
Consensus estimates
Access analyst consensus estimates, valuation multiples, and revenue segments splits.
All IR material in one place
The easiest way to stay updated during earnings season.
Global coverage
All events from public companies. Live and recorded.
Just click and listen
No webcast links. No manual registrations.
excellent app, it gives me free access to company earnings calls and annual reports. I also love the convenience of calls being available offline so I can listen in whilst doing other things and even when internet or WiFi isn't available.
)
Leroy DaleyApp Store
One of the very few apps you could call perfect. If something was to add to it, maybe the share price of the company when you search for it, but it's already excellent.
)
Eferix Drawings Google Play
This is genuinely one of the cleanest and fastest finance apps out there to track the market.
anuj283App Store
excellent app, it gives me free access to company earnings calls and annual reports. I also love the convenience of calls being available offline so I can listen in whilst doing other things and even when internet or WiFi isn't available.
Leroy DaleyApp Store
One of the very few apps you could call perfect. If something was to add to it, maybe the share price of the company when you search for it, but it's already excellent.
Eferix Drawings Google Play
This is genuinely one of the cleanest and fastest finance apps out there to track the market.
anuj283App Store
I can't remember the last time an app had such a positive impact on my investment process.
)
@ankurshah47_ x.com
Love the app! Quartr makes it really easy to keep track of earnings calls. It also includes the reports and slides to make it easier to follow along.
Amina0781App Store
Quartr is amazing, no way around it. It is the best right now for earnings calls, presentations, and the like.
@theshortbearx.com
I can't remember the last time an app had such a positive impact on my investment process.
@ankurshah47_ x.com
Love the app! Quartr makes it really easy to keep track of earnings calls. It also includes the reports and slides to make it easier to follow along.
Amina0781App Store
Quartr is amazing, no way around it. It is the best right now for earnings calls, presentations, and the like.
@theshortbearx.com
)
)
Frequently asked questions
Chosa Oncology AB is a Sweden-based biotechnology company focused on the development of innovative cancer therapies. The company specializes in identifying and advancing novel treatment options targeting unmet medical needs in oncology. The company is headquartered in Stockholm, Sweden, and its shares are listed on the Spotlight Stock Market.
Quartr provides global coverage of all investor relation material from public companies.
Mobile app: Research anytime, anywhere with the #1 app for live earnings calls, transcripts, analyst estimates, and more. All for free.
Desktop (Quartr Pro): The leading platform for qualitative research, used daily by top firms and financial institutions.
Quartr API: Build custom solutions powered by live earnings calls, live transcripts, filings and reports, slide presentations, and more.
Yes, the Quartr mobile app is free on both iOS and Android.
Yes. Quartr provides global, industry-leading live coverage of company events such as regular earnings calls, capital markets days, M&A announcements, and investor conferences. Live with zero delays. Just click and listen.
Yes, capturing important takeaways is as simple as it gets. Even during your lunch run or commute.
Yes. Follow the companies that matter to you. Get a personalized feed with real-time updates, a tailored earnings calendar, and instant alerts when earnings calls go live.
Yes. Set keyword alerts for any company, product, or competitor. Get notified the moment they're mentioned, regardless of who's talking.
Explore our global coverage